Spero Therapeutics (SPRO) Non-cash Items (2017 - 2026)

Spero Therapeutics (SPRO) has 10 years of Non-cash Items data on file, last reported at $182000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items changed N/A year-over-year to $182000.0; the trailing twelve-month figure through Mar 2026 stood at $182000.0 (changed N/A YoY), and the FY2025 full-year result was $58000.0, down 97.83% from the prior year.
• Non-cash Items for Q1 2026 stood at $182000.0, up from $58000.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $20.9 million in Q3 2025 and bottomed at $1000.0 in Q4 2022.
• The 5-year median for Non-cash Items is $30000.0 (2022), against an average of $2.3 million.
• The widest annual swing landed in 2022, when Non-cash Items slumped 100.0%; it then jumped 261444.0% in 2024.
• A 5-year view of Non-cash Items shows it stood at $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then surged by 261444.0% to $2.6 million in 2024, then tumbled by 97.78% to $58000.0 in 2025, then soared by 213.79% to $182000.0 in 2026.
• The last three Non-cash Items figures came in at $182000.0 (Q1 2026), $58000.0 (Q4 2025), and $20.9 million (Q3 2025), per Business Quant data.

Peer Comparison